首页> 外国专利> method for treating an individual at risk for chronic kidney disease (ckd), method for treating an individual sensitive to or suffering from soft tissue calcification and method for treating an individual susceptible to or suffering from secondary hyperparathyroidism

method for treating an individual at risk for chronic kidney disease (ckd), method for treating an individual sensitive to or suffering from soft tissue calcification and method for treating an individual susceptible to or suffering from secondary hyperparathyroidism

机译:治疗有慢性肾脏疾病风险的个体的方法,对软组织钙化敏感或患有软组织钙化的个体的治疗方法以及对继发性甲状旁腺功能亢进敏感或患有继发性甲状旁腺功能亢进的个体的治疗方法

摘要

METHOD TO TREAT AN INDIVIDUAL AT RISK OF HAVING CHRONIC KIDNEY DISEASE (CKD), METHOD TO TREAT A SENSITIVE INDIVIDUAL TO OR SUFFER FROM CALCIFICATION OF SOFT FABRICS AND METHOD TO TREAT A HIGHLY SUSPICIENT OR SECURIDLY INDIVIDUAL. An individual with symptoms of chronic kidney disease (CKD) who has no end-stage renal disease (ESRD) may be treated by oral administration of a pharmaceutical composition as an active ingredient with a therapeutically effective amount of a non-toxic lantanum compound. Administration of a lantanum compound may prevent the progress of CKD, treat soft tissue calcification, and treat secondary hyperparathyroidism.
机译:治疗具有慢性肾脏疾病(CKD)风险的个体的方法,治疗软化纤维或敏感的敏感个体的方法以及治疗高度敏感或安全的个体的方法。没有终末期肾脏病(ESRD)的具有慢性肾脏病(CKD)症状的个体可以通过口服药物组合物作为有效成分与治疗有效量的无毒镧类药物进行治疗。服用镧类化合物可预防CKD的进展,治疗软组织钙化和治疗继发性甲状旁腺功能亢进。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号